期刊文献+

RA538基因功能片段的克隆和对HL-60细胞的作用 被引量:2

THE CLONING OF A FUNCTIONAL DNA FRAGMENT OFRA538 GENE AND ITS EFFECT ON HL-60 CELLS
原文传递
导出
摘要 RA538基因是用维甲酸在体外迫使食管癌细胞系发生终未分化,建立分化前后的cDNA文库,进行递减杂交后分离所得。转移到食管癌细胞后可抑制其增殖,引起细胞脱落和死亡。测定和分析RA538cDNA序列,靠近5'端有一个可能的蛋白编码区。为研究RA538基因的功能,用多聚酶链反应技术扩增分离了这个可能编码区DNA序列,借逆转录病毒载体转入白血病细胞,发现对HL-60细胞的生长有明显的抑制作用,提示它在肿瘤基因治疗中有潜在应用价值。 A538 gene was isolated from the EC8712esophageal cancer cell line treated with retinoic acid . Itsuppresses the proliferation of esophageal cancer cell invitro. There is a potential protein ceding fragment nearits 5' end. We amplifed and isolated this fragment byPCR niethod . and cloned it into a retrovirus vector . Af-ter introducing the recombinant retrovirus vector intoHL-60 cell by lipofectin, we find it can suppress thegrowth of HL-60 cell effectively. The result suggeststhat the protein coding fragment of RA538 gene may beused for gene therapy of cancer.
出处 《中华血液学杂志》 CAS CSCD 北大核心 1995年第5期229-231,共3页 Chinese Journal of Hematology
关键词 基因治疗 逆转录病毒 维甲酸 白血病 抑癌基因 Gene therapy RetrovirusRetinoic acid Leukemic cellTumor suppressing gene
  • 相关文献

参考文献1

同被引文献18

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J ]. CA Cancer J Clin, 2011,61 ( 2 ) : 69 - 90. 被引量:1
  • 2Donnelly RP, Kotenko SV. Interferon-lambda : a new addition to an old family [ J ]. J Interferon Cytokine Res. 2010,30 ( 8 ) :555 - 564. 被引量:1
  • 3Li Q,Kawamura K,Ma G,et al. Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces an- ti-tumour effects in combination with anti-cancer agents [ J ]. Eur J Cancer, 2010,46( 1 ) : 180 - 190. 被引量:1
  • 4Li Q, Kawamura K, Okamoto S, et al. Adenoviruses-mediated trans- duction of human oesophageal carcinoma cells with the interferon-λ genes produced anti-tumour effects [ J ]. Br J Cancer, 2011,105 (9) :1302 -1312. 被引量:1
  • 5Raulet DH, Gasser S, Gowen BG, et al. Regulation of ligands for the NKG2D activating receptor[ J]. Annu Rev Immunol, 2013,31:413 -441. 被引量:1
  • 6Jiang Y,Kimchi E, Ajani JA. Localized squamous cell carcinoma of the esophagus: bimodality or trimodality approach? [ J]. Future Oncol, 2009,5(2) :157 - 161. 被引量:1
  • 7Rodriguez CP, Adelstein D J, Rice TW, et al. A phase Ⅱ study of perioperative concurrent chemotherapy, gefitinib, and hyperfraction- ated radiation followed by maintenance gefitiuib in locoregionally advanced esophagus and gastroesophageal junction cancer [ J ]. J Thorac Oncol, 2010,5(2) :229 -235. 被引量:1
  • 8Li G, Hu W,Wang J, et al. Phase Ⅱ study of concurrent chemora- diation in combination with erlotinib for locally advanced esophage- al carcinoma[J]. Int J Radiat Oncol Biol Phys, 2010,78(5) :1407 -1412. 被引量:1
  • 9Wainberg ZA, Lin LS, DiCarlo B, et al. Phase Ⅱ trial of modified FOLFOX6 and erlotinih in patients with metastatic or advanced ad- of the oesophagus and gastro-oesophageal junction [J]. Br J Cancer, 2011,105(6) :760 -765. 被引量:1
  • 10Pinto C, Di Fabio F, Barone C, et al. Phase Ⅱ study of cetuximab in combination with cisplatin and docetaxel in patients with untreat-ed advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study) [J]. Br J Cancer, 2009, 101 (8): 1261 - 1268. 被引量:1

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部